• In recent months, the DESAL4ALL consortium, including DuPont, Acciona, Danfoss and H2O Innovation, advanced to the semifinals of the XPRIZE Water Scarcity competition, showcasing DuPont’s next‑generation reverse osmosis technology for more energy‑efficient, scalable desalination.
• At the same time, DuPont’s membranes are being highlighted in the emerging osmotic energy market, underscoring its role in technologies that support industrial ESG goals and cleaner water and power solutions worldwide.
• We’ll now examine how DuPont’s XPRIZE-recognized desalination technology could influence its investment narrative around water-focused growth.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.

DuPont de Nemours Investment Narrative Recap

To own DuPont today, you need to believe the company can turn its sharpened focus on water and healthcare solutions into steadier earnings, while managing PFAS liabilities and portfolio reshaping. The XPRIZE Water Scarcity progress and visibility in osmotic energy reinforce the water growth story but do not clearly change the near term picture, where legal overhangs and execution on separations remain the most immediate risks to watch.

Among recent announcements, DuPont’s April 9 launch of new FilmTec Fortilife reverse osmosis elements ties directly into the XPRIZE news. It shows the company is not just showcasing prototype technology but adding higher performance membranes to its commercial lineup in high salinity and industrial applications, which sit at the heart of the water focused growth catalyst investors are watching most closely.

Yet beneath the promise of cleaner water and membranes, investors should be aware that lingering PFAS litigation risk could still...

DuPont de Nemours' narrative projects $14.0 billion revenue and $1.7 billion earnings by 2028. This requires 3.7% yearly revenue growth and about a $1.6 billion earnings increase from $71.0 million today.

Uncover how DuPont de Nemours' forecasts yield a $56.12 fair value, a 17% upside to its current price.

Exploring Other Perspectives

More cautious analysts already expected only about 3.7% annual revenue growth and US$814.4 million of earnings by 2029, so this new desalination spotlight could either soften or reinforce those concerns, depending on how you view DuPont’s ability to offset long term environmental and input cost pressures.

Explore 4 other fair value estimates on DuPont de Nemours - why the stock might be worth just $50.00!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DuPont de Nemours research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free DuPont de Nemours research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DuPont de Nemours' overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Outshine the giants: these 13 early-stage AI stocks could fund your retirement.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.